The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...
A US Supreme Court fight over how branded drugs’ makers must plead induced infringement in “skinny-label” patent suits could ...
After passing on one skinny label case a few years ago, the U.S. Supreme Court agreed to delve into the dark hole the Federal Circuit has dug for drug label carveouts that allow generic drugs and ...
Key Takeaways Supreme Court to decide if “generic version” marketing can support induced infringement claims. On Jan. 16, ...
The military’s prohibited supplement list struggles to keep pace with stimulant analogs, misleading labels, and on-base sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback